Patil Automation Submits Monitoring Agency Report for Quarter Ended March 31, 2026 Under Regulation 32
Patil Automation Limited submitted its Monitoring Agency Report for the quarter ended March 31, 2026, to the NSE, covering the utilization of IPO proceeds aggregating Rs. 69.61 crore. As of March 31, 2026, Rs. 51.14 crore has been cumulatively utilized, with Rs. 18.47 crore remaining deployed in a fixed deposit with ICICI Bank at a return of 6.35%. A delay in the setup of the new manufacturing facility has been noted, with the board extending the utilization timeline to September 30, 2026 via a resolution dated March 30, 2026. A change in the plant's location, approved by the board on August 04, 2025, was also flagged as relevant information for investors, while no material deviations from the offer document objects were reported.

*this image is generated using AI for illustrative purposes only.
Patil Automation Limited has filed its Monitoring Agency Report for the quarter ended March 31, 2026, with the National Stock Exchange of India. The submission, dated May 07, 2026, was made pursuant to Regulation 32(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Regulation 41(4) of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. The report was prepared by CARE Ratings Limited, the designated Monitoring Agency, and pertains to the utilization of proceeds raised through the company's Initial Public Offer (IPO).
IPO Issue Overview
The company's IPO, which was open during June 16, 2025, to June 18, 2025, raised an aggregate amount of Rs. 69.61 crore through the issuance of equity shares. The promoters of the company are Manoj Pandurang Patil, Aarti Manoj Patil, and Prafulla Pandurang Patil. Patil Automation operates in the industrial machinery segment, specifically catering to the automotive industry. The following table summarizes the planned allocation of IPO proceeds as per the offer document:
| Object: | Original Cost (Rs. Crore) |
|---|---|
| Funding of capital expenditure towards setup of new manufacturing facility | 62.01 |
| Repayment of a portion of certain borrowings | 4.00 |
| General Corporate Purpose | 0.56 |
| Issue Expenses | 3.04 |
| Total | 69.61 |
Fund Utilization as of March 31, 2026
As of the quarter ended March 31, 2026, the company has cumulatively utilized Rs. 51.14 crore of the total IPO proceeds, leaving an unutilized balance of Rs. 18.47 crore. The following table presents the detailed utilization progress across all objects:
| Object: | Proposed (Rs. Crore) | Opening Balance (Rs. Crore) | Utilized During Quarter (Rs. Crore) | Closing Balance (Rs. Crore) | Unutilized (Rs. Crore) |
|---|---|---|---|---|---|
| New manufacturing facility capex | 62.01 | 35.91 | 7.62 | 43.54 | 18.47 |
| Repayment of borrowings | 4.00 | 3.30 | 0.70 | 4.00 | 0.00 |
| General Corporate Purpose | 0.56 | 0.56 | 0.00 | 0.56 | 0.00 |
| IPO Expense | 3.05 | 2.94 | 0.11 | 3.05 | 0.00 |
| Total | 69.61 | 42.71 | 8.43 | 51.14 | 18.47 |
The Monitoring Agency noted that proceeds for the manufacturing facility were utilized for payments towards plant and machinery, routed through the company's cash credit account. Reimbursements were subsequently taken through the closure of fixed deposit proceeds created post transfer of funds into the cash credit account. Given the commingling of funds in the cash credit account, the Monitoring Agency primarily relied on the Chartered Accountant certificate and Management Certificate for verifying utilization.
Deployment of Unutilized Proceeds
The unutilized IPO proceeds of Rs. 18.47 crore have been deployed in a fixed deposit with ICICI Bank. The details of this deployment are as follows:
| Parameter: | Details |
|---|---|
| Instrument | Fixed Deposit with ICICI Bank |
| Amount Invested (Rs. Crore) | 18.47 |
| Maturity Date | 26-06-2028 |
| Return on Investment (%) | 6.35% |
Key Observations and Deviations
The Monitoring Agency report flags a delay in the utilization of funds allocated for the setup of the new manufacturing facility. The original completion timeline as per the offer document was March 31, 2026; however, the implementation remains ongoing. The company has passed a board resolution dated March 30, 2026, extending the utilization deadline to September 30, 2026. The exact number of days of delay has been noted as not ascertainable by the Monitoring Agency.
Additionally, the report highlights a change in the location for setting up the manufacturing plant, which was approved by the board via a resolution dated August 04, 2025. The company has received electricity approval from Maharashtra State Electricity Distribution Company Limited, while other statutory approvals remain in process. No material deviation from the objects of the issue has been reported, and shareholder approval for material deviations was noted as not applicable. The means of finance for the disclosed objects have not changed, and no major deviation was observed over earlier monitoring agency reports.
General Corporate Purpose Utilization
For the quarter ended March 31, 2026, there was nil utilization under the General Corporate Purpose head. As per the offer document, the company had earmarked Rs. 55.77 Lakhs towards general corporate purposes. The full amount of Rs. 0.56 crore allocated to this object had already been utilized in prior periods, with no additional deployment recorded during the quarter under review.
Historical Stock Returns for Patil Automation
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +3.61% | +6.76% | +41.74% | +9.63% | +16.44% | +16.44% |
Will Patil Automation be able to complete the new manufacturing facility setup by the revised deadline of September 30, 2026, and what are the potential consequences if another extension becomes necessary?
How might the delay in commissioning the new manufacturing facility impact Patil Automation's revenue growth and order fulfillment capacity in the automotive machinery segment over the next 12-18 months?
What are the pending statutory approvals required for the new manufacturing plant location, and could regulatory hurdles further delay operations beyond the extended September 2026 timeline?




























